These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of obesity and hyperinsulinemia in the insulin resistance of obese subjects with the clinical triad of polycystic ovaries, hirsutism and acanthosis nigricans. Wajchenberg BL, Giannella-Neto D, Lerario AC, Marcondes JA, Ohnuma LY. Horm Res; 1988 Jul 01; 29(1):7-13. PubMed ID: 3397043 [Abstract] [Full Text] [Related]
3. [Extreme insulin resistance type A]. Kobayashi M. Nihon Rinsho; 1994 Oct 01; 52(10):2629-36. PubMed ID: 7983789 [Abstract] [Full Text] [Related]
4. Impaired insulin degradation in a patient with insulin resistance and acanthosis nigricans. Ferrannini E, Muggeo M, Navalesi R, Pilo A. Am J Med; 1982 Jul 01; 73(1):148-54. PubMed ID: 7046438 [Abstract] [Full Text] [Related]
5. Insulin resistance, acanthosis nigricans, and polycystic ovaries associated with a circulating inhibitor of postbinding insulin action. Harrison LC, Dean B, Peluso I, Clark S, Ward G. J Clin Endocrinol Metab; 1985 May 01; 60(5):1047-52. PubMed ID: 3884647 [Abstract] [Full Text] [Related]
6. Acromegaly with polycystic ovaries, hyperandrogenism, hirsutism, insulin resistance and acanthosis nigricans: a case report. Unal A, Sahin Y, Keleştimur F. Endocr J; 1993 Apr 01; 40(2):207-11. PubMed ID: 7951506 [Abstract] [Full Text] [Related]
7. Primary amenorrhea associated with hirsutism, acanthosis nigricans, dermoid cysts of the ovaries and a new type of insulin resistance. Imperato-McGinley J, Peterson RE, Sturla E, Dawood Y, Bar RS. Am J Med; 1978 Aug 01; 65(2):389-95. PubMed ID: 686026 [Abstract] [Full Text] [Related]
8. Insulin resistance with acanthosis nigricans and acral hypertrophy. Holdaway IM, Frengley PA, Graham FM, Wong M. N Z Med J; 1984 May 09; 97(755):286-8. PubMed ID: 6587221 [Abstract] [Full Text] [Related]
9. [A case of insulin receptor abnormality (type A)]. Kamada T, Horinosono M, Nishi M, Setoyama M, Oki T, Nagata Y, Arima T, Tashiro M, Otsuji S. Igaku Kenkyu; 1992 Feb 09; 62(1):25-9. PubMed ID: 1523941 [Abstract] [Full Text] [Related]
10. Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization. Dunaif A, Hoffman AR, Scully RE, Flier JS, Longcope C, Levy LJ, Crowley WF. Obstet Gynecol; 1985 Oct 09; 66(4):545-52. PubMed ID: 3900841 [Abstract] [Full Text] [Related]
11. Insulin resistance, acanthosis nigricans, and normal insulin receptors in a young woman: evidence for a postreceptor defect. Bar RS, Muggeo M, Roth J, Kahn CR, Havrankova J, Imperato-McGinley J. J Clin Endocrinol Metab; 1978 Sep 09; 47(3):620-5. PubMed ID: 400728 [Abstract] [Full Text] [Related]
12. Tyrosine kinase activity of the insulin receptor of patients with type A extreme insulin resistance: studies with circulating mononuclear cells and cultured lymphocytes. Grunberger G, Comi RJ, Taylor SI, Gorden P. J Clin Endocrinol Metab; 1984 Dec 09; 59(6):1152-8. PubMed ID: 6333431 [Abstract] [Full Text] [Related]
13. Demonstration of a primary (? genetic) defect in insulin receptors in fibroblasts from a patient with the syndrome of insulin resistance and acanthosis nigricans type A. Kahn CR, Podskalny JM. J Clin Endocrinol Metab; 1980 Jun 09; 50(6):1139-41. PubMed ID: 6989852 [Abstract] [Full Text] [Related]
14. Ovarian pathology associated with insulin resistance and acanthosis nigricans. Annos T, Taymor ML. Obstet Gynecol; 1981 Nov 09; 58(5):662-4. PubMed ID: 7301247 [Abstract] [Full Text] [Related]
16. Hyperandrogenism, insulin resistance, acanthosis nigricans, and systemic lupus erythematosis associated with insulin receptor antibodies. Kellett HA, Collier A, Taylor R, Sawers JS, Benton C, Doig A, Baird D, Clarke BF. Metabolism; 1988 Jul 09; 37(7):656-9. PubMed ID: 3386533 [Abstract] [Full Text] [Related]
17. Ovarian activity before and after gonadal suppression by GnRH-a in patients with polycystic ovary syndrome, hyperandrogenism, hyperinsulinism and acanthosis nigricans. Motta EL, Baracat EC, Haidar MA, Juliano I, Lima GR. Rev Assoc Med Bras (1992); 1998 Jul 09; 44(2):94-8. PubMed ID: 9699325 [Abstract] [Full Text] [Related]
18. Clinical course of genetic diseases of the insulin receptor (type A and Rabson-Mendenhall syndromes): a 30-year prospective. Musso C, Cochran E, Moran SA, Skarulis MC, Oral EA, Taylor S, Gorden P. Medicine (Baltimore); 2004 Jul 09; 83(4):209-222. PubMed ID: 15232309 [Abstract] [Full Text] [Related]
19. Long-term follow up in type A insulin resistant syndrome treated by insulin-like growth factor I. Ishihama H, Suzuki Y, Muramatsu K, Nagai M, Kokubo M, Shiraya H, Kawakita A, Nishimura Y, Imamura T, Kobayashi M. Arch Dis Child; 1994 Aug 09; 71(2):144-6. PubMed ID: 7944536 [Abstract] [Full Text] [Related]
20. Characterization of binding and phosphorylation defects of erythrocyte insulin receptors in the type A syndrome of insulin resistance. Grigorescu F, Flier JS, Kahn CR. Diabetes; 1986 Feb 09; 35(2):127-38. PubMed ID: 3510919 [Abstract] [Full Text] [Related] Page: [Next] [New Search]